Last reviewed · How we verify
NCT07089407
Ten Year Follow up of Convergent Profile Implants
trial testing Dental implant placement in Peri-implant Bone Loss in 97 participants. Completed in 1 July 2025.
1 July 2024
Quick facts
| Lead sponsor | University of Cagliari |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 97 |
| Start date | 1 January 2023 |
| Primary completion | 1 July 2024 |
| Estimated completion | 1 July 2025 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Dental implant placement
Conditions studied
- Peri-implant Bone Loss — all drugs for Peri-implant Bone Loss →
- Peri-Implant Tissues — all drugs for Peri-Implant Tissues →
Sponsor
University of Cagliari
Who can join
Eligibility, any sex, with Peri-implant Bone Loss or Peri-Implant Tissues. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to evaluate the marginal bone level (MBL) and pink aesthetic score (PES) changes on the short, medium and long-term, on a retrospective cohort of patients who received at least one "biotype implant" (DEI ITALIA SRL, Mercallo VA, Italy) with convergent transmucosal profile. Ninety-seven patients with at least one periapical x-ray taken on the day of implant placement and at least one taken in the following 10 years were included for MBL analysis and 90 patients who had at least one photograph taken on the day of implant loading, and one taken in the following 10 years for PES analysis. The radiographs were divided into 4 groups: (1) implant placement; (2) 1-2 years follow-up (short-term); (3) 3-6 years follow-up (medium-term); (4) ≥7 years follow-up (long-term). Photographs were grouped similarly, except that the first group was relative to the day of prosthetic loading. MBL was measured using ImageJ software. Results were analyzed with Generalized Estimating Equations method using SPSS software, the P value was set at \<0.05 for significance.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07089407
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dental implant placement
Trials testing the same drug.
- NCT07534787 — Clinical and Radiographic Evaluation of Ridge Splitting With Simultaneous Implant Placement Covered With Concentrated Gr · NA · not yet recruiting
- NCT07104370 — Freeze-dried Bone Allograft vs Autologous Bone Blocks in the Lateral Augmentation of the Jaws · NA · recruiting
- NCT07082244 — Implant Phenotype Modification Via GBR and ADM · NA · recruiting
- NCT07348770 — Cold Plasma Effects on Dental Implant Stability · NA · completed
- NCT06764654 — Randomized Clinical Study Comparing Two Guided Surgery Techniques for Free-end Implant Placement · NA · recruiting
Other University of Cagliari trials
Trials by the same sponsor.
- NCT06872151 — Evaluation of the Effectiveness of a Topical Medical Device in Wound Healing and Symptom Relief in the Postoperative Per · Phase 4 · completed
- NCT06523920 — Protecting Autologous Free Flaps From Ischemia/Reperfusion Damage With Cold Storage. · NA · not yet recruiting
- NCT06484205 — Evaluation of the Effectiveness of the World Health Organization QualityRights Training in Italy · NA · recruiting
- NCT06526962 — 5Fr Bipolar Electrode vs. Conical Optical 5Fr Fibers for Dual Wave-length Diode Laser for Hysteroscopic Polypectomy · recruiting
- NCT06579378 — Feasibility Study of Virtual Sail 3D in Cognitive Functions · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07089407 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Cagliari
- Last refreshed: 28 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07089407.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing